(Q38020017)

27 August 2017

title

Should probiotics be tested on ex vivo organ culture models? (English)

1 reference

27 August 2017

0 references

Katerina Tsilingiri

1

1 reference

27 August 2017

Maria Rescigno

series ordinal

2

1 reference

27 August 2017

publication date

20 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

3

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

442-448

1 reference

Use of probiotics as prophylaxis for postoperative infections

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Probiotics in the treatment of human inflammatory bowel diseases: update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Functional cell models of the gut and their applications in food microbiology--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Critical appraisal of the current practice in murine TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

The intestinal epithelial barrier in the control of homeostasis and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Human colon tissue in organ culture: preservation of normal and neoplastic characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Development of a vitamin D-responsive organ culture system for adult and old rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Lactobacillus and Bifidobacterium species do not secrete protease that cleaves the MUC2 mucin which organises the colon mucus.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Probiotics in clostridium difficile Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Novel vaccine development strategies for inducing mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.20885

21 January 2018

Identifiers

DOI

10.4161/GMIC.20885

1 reference

27 August 2017

1 reference